This week, cardiologists learned for the first time they have been examining black holes for decades and did not know it ...
April 12, 2019
April 10, 2019 —Smart speakers customarily used in your living room can act as an aid to physicians in hospital ...
April 10, 2019
April 9, 2019 — DiA Imaging Analysis announced the launch of LVivo SAX, a cardiac analysis tool that helps clinicians ...
April 09, 2019
Feature | Cardiovascular Ultrasound | Dave Fornell, Editor
Echocardiography reporting systems are usually integrated with, or offered as an add-on module for a cardiovascular ...
April 08, 2019
April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the 2019 American College ...
April 05, 2019
April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...
April 03, 2019
April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) maga ...
April 01, 2019
March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...
March 29, 2019
March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...
March 29, 2019
March 27, 2019 — Training interventional radiologists to perform endovascular thrombectomies results in positive ...
March 27, 2019![New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.](/sites/default/files/styles/content_feed_medium/public/Entresto_bottles.jpg?itok=sp56E5GI)
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril ...
March 27, 2019
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the annual ...
March 27, 2019
March 27. 2019 — A newly released expert consensus statement provides recommendations for the safe and effective ...
March 27, 2019
March 26, 2019 — Johns Hopkins Medicine now has access to the first Ultra-High Resolution computed tomography (UHR CT) s ...
March 26, 2019
Khaldoun Tarakji, M.D., MPH, staff physician in the Section of Electrophysiology and Pacing in the Robert and Suzanne ...
March 26, 2019